15-LOX-1: A novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells

Journal of the National Cancer Institute

Volumn 92, Issue 14, 2000, Pages 1136-1142

  Shureiqi, Imad ^a   Chen, Dongning ^a   Lee, J Jack ^a   Yang, Peiying ^a   Newman, Robert A ^a   Brenner, Dean E ^b   Lotan, Reuben ^a   Fischer, Susan M ^a   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 15 LIPOXYGENASE; CAFFEIC ACID; CORIOLIC ACID; IBUPROFEN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; SULINDAC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034686624     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.14.1136     Document Type: Article

References (53)

1. Recent advances in chemoprevention of cancer
2. Cancer chemoprevention: Progress and promise
3. Aspirin and the risk of colorectal cancer in women
4. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
6. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
7. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
8. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
9. Apoptosis in cancer
10. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion
11. Non-steroidal anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis
12. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
13. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
14. Aspirin, NSAIDs, and colon cancer prevention: Mechanisms?
15. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
16. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
17. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
18. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy
19. Metabolism of oxidized linoleic acid: Characterization of 13-hydroxyoctadecadienoic acid dehydrogenase activity from rat colonic tissue
20. Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets
21. In vivo activation of an omega-6 oxygenase in human skin
22. Discovery of a second 15S-lipoxygenase in humans
23. Expression of 15-lipoxygenase-1 in human colorectal cancer
24. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers
25. Activation of a 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen
26. Nonsteroidal anti-inflammatory drugs stimulate 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes
27. Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related
28. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells
29. The expression of 15-lipoxygenase gene and the presence of functional enzyme in cytoplasm and nuclei of pregnancy human myo-metria
30. Significance and immunoassay of 9- and 13-hydroxyoctadecadienoic acids
31. Characterization and inhibition of 15-lipoxygenase in human monocytes: Comparison with soybean 15-lipoxygenase
32. Caffeic acid is a selective inhibitor for leukotriene biosynthesis
33. Phenolic compounds and an analog as superoxide anion scavengers and antioxidants
34. FLAP: A novel drag target for inhibiting the synthesis of leukotrienes
35. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation
36. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
37. LC-MS-MS determination of exemestane in human plasma with heated nebulizer interface following solid-phase extraction in the 96 well plate format
38. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system
39. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry
40. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines
41. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
42. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process
43. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells
44. Lipoxygenase inhibitors as potential cancer chemopreventives
45. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
46. Lipid hyperperoxidase-induced apoptosis: Lack of inhibition by Bcl-2 over-expression
47. Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate induced cell differentiation
48. Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin
49. Arachidonate has protumor-promoting action that is inhibited by linoleate in mouse skin carcinogenesis
50. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-gamma
51. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
52. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
53. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells